Kcentra 500 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FCFN9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,490
Award facts
- Contract value 100% obligated
- $25,490.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,490.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 500-unit vials of Kcentra. This firm fixed-price delivery order, issued on January 6, 2026, with an ultimate completion date of January 28, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award was made without any identified subcontractors, with performance to occur at the vendor's Park Ridge facility.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical and medical consumable support to Department of Defense healthcare facilities worldwide. The underlying IDC, valued at $499.9 million with a completion date of December 31, 2036, authorizes DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, biologics, and medical consumables to support military healthcare operations globally. DMS Pharmaceutical Group's established performance on numerous prior delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FCFN9?
SPE2DR26FCFN9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FCFN9 worth?
The government has obligated $25,490 on SPE2DR26FCFN9.
Is contract SPE2DR26FCFN9 an order under another contract?
Yes. SPE2DR26FCFN9 is a delivery order under SPE2DR25D9133, an indefinite delivery contract.
Was contract SPE2DR26FCFN9 competed?
The extent of competition for SPE2DR26FCFN9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award